{"entity":{"type":"insider","cik":"0001754125","url":"/insider/0001754125","json_url":"/insider/0001754125.json","name":"Snyder Douglas B.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":11,"first":"2019-02-28","last":"2021-04-08","span_basis":"filed_date"},"name_variants":[{"name":"Snyder Douglas B.","source":"filing","n_filings":11,"first_seen":"2019-02-28","last_seen":"2021-04-08"}],"transactions":[{"id":4653734,"accession":"0000899243-21-015430","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-015430","line_url":"/filing/0000899243-21-015430#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8400.0,"shares_display":"8,400","price_per_share":18.12,"price_display":"18.12","price_state":"stated","total_value":152208.0,"total_display":"152,208.00","total_whole":"152,208","shares_owned_after":61848.0,"shares_owned_after_display":"61,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-26","filed_date":"2021-04-08","scope":"insider"},{"id":2288483,"accession":"0000899243-20-033216","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-033216","line_url":"/filing/0000899243-20-033216","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26904.0,"shares_display":"26,904","price_per_share":11.0128545941124,"price_display":"11.01","price_state":"stated","total_value":296289.84,"total_display":"296,289.84","total_whole":"296,290","shares_owned_after":23660.0,"shares_owned_after_display":"23,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-09","scope":"insider","n_lines":6},{"id":2732495,"accession":"0000899243-20-026863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-026863","line_url":"/filing/0000899243-20-026863#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14400.0,"shares_display":"14,400","price_per_share":8.13,"price_display":"8.13","price_state":"stated","total_value":117072.0,"total_display":"117,072.00","total_whole":"117,072","shares_owned_after":26904.0,"shares_owned_after_display":"26,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-30","filed_date":"2020-10-02","scope":"insider"},{"id":3075326,"accession":"0000899243-20-022190","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-022190","line_url":"/filing/0000899243-20-022190#line-5","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":9.4,"price_display":"9.40","price_state":"stated","total_value":225600.0,"total_display":"225,600.00","total_whole":"225,600","shares_owned_after":41304.0,"shares_owned_after_display":"41,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-11","filed_date":"2020-08-12","scope":"insider"},{"id":3309917,"accession":"0000899243-20-018765","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-018765","line_url":"/filing/0000899243-20-018765#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9804.0,"shares_display":"9,804","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":102942.0,"total_display":"102,942.00","total_whole":"102,942","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-06","filed_date":"2020-07-08","scope":"insider"},{"id":2132493,"accession":"0000899243-20-006998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-006998","line_url":"/filing/0000899243-20-006998#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2568.0,"shares_display":"2,568","price_per_share":8.32,"price_display":"8.32","price_state":"stated","total_value":21365.76,"total_display":"21,365.76","total_whole":"21,366","shares_owned_after":67296.0,"shares_owned_after_display":"67,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2100474,"accession":"0000899243-20-006331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-006331","line_url":"/filing/0000899243-20-006331","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3876.0,"shares_display":"3,876","price_per_share":9.17185758513932,"price_display":"9.17","price_state":"stated","total_value":35550.12,"total_display":"35,550.12","total_whole":"35,550","shares_owned_after":70104.0,"shares_owned_after_display":"70,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-28","scope":"insider","n_lines":2},{"id":7857933,"accession":"0000899243-19-022228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-022228","line_url":"/filing/0000899243-19-022228#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5424.0,"shares_display":"5,424","price_per_share":13.04,"price_display":"13.04","price_state":"stated","total_value":70728.96,"total_display":"70,728.96","total_whole":"70,729","shares_owned_after":73740.0,"shares_owned_after_display":"73,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-21","scope":"insider"},{"id":7909577,"accession":"0000899243-19-021736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-021736","line_url":"/filing/0000899243-19-021736#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3756.0,"shares_display":"3,756","price_per_share":13.88,"price_display":"13.88","price_state":"stated","total_value":52133.28,"total_display":"52,133.28","total_whole":"52,133","shares_owned_after":79164.0,"shares_owned_after_display":"79,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-14","scope":"insider"},{"id":7886331,"accession":"0000899243-19-019500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-019500","line_url":"/filing/0000899243-19-019500#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4968.0,"shares_display":"4,968","price_per_share":14.42,"price_display":"14.42","price_state":"stated","total_value":71638.56,"total_display":"71,638.56","total_whole":"71,639","shares_owned_after":82920.0,"shares_owned_after_display":"82,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-09","filed_date":"2019-07-11","scope":"insider"},{"id":8757887,"accession":"0000899243-19-005256","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-19-005256","line_url":"/filing/0000899243-19-005256","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754125","owner_name":"Snyder Douglas B.","owner_display_name":"Snyder Douglas B.","owner_url":"/insider/0001754125","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4644.0,"shares_display":"4,644","price_per_share":12.425219638242893,"price_display":"12.43","price_state":"stated","total_value":57702.72,"total_display":"57,702.72","total_whole":"57,703","shares_owned_after":6636.0,"shares_owned_after_display":"6,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-28","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001351288","name":"GW PHARMACEUTICALS PLC","url":"/issuer/0001351288","role":"Officer (Chief Legal Officer)","n_filings":11,"first_seen":"2019-02-28","last_seen":"2021-04-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001754125","retrieved_at":"2026-08-23T15:31:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}